| | | Single nucleotide variant (missense variant) | Ataxia-telangiectasia syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Ataxia-telangiectasia syndrome +4 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 1 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (nonsense +1 more) | Ataxia-telangiectasia syndrome +5 more | |
| | | Single nucleotide variant (nonsense +1 more) | Ataxia-telangiectasia syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +1 more | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 5 +7 more | |
| | | Single nucleotide variant (missense variant +1 more) | Li-Fraumeni syndrome 1 +17 more | GPathogenic/Likely pathogenic |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +6 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | NICE approved PARP inhibitor treatment +21 more | |
| | | Deletion (splice donor variant) | Hereditary breast ovarian cancer syndrome +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +5 more | GPathogenic/Likely pathogenic |